Hataka R. Minami
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hataka R. Minami has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Neal R. Barshes
Division of Vascular Surgery and Endovascular Therapy, Michael E. DeBakey Department of Surgery, Baylor College of Medicine
3 shared publications Besma J. Nejim
Division of Vascular Surgery and Endovascular Therapy, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX
2 shared publicationsDilbahar Mohar
University of California, Irvine, Medical Center, 101 The City Drive South, Orange, California 92868, United States
2 shared publicationsErin K. Greenleaf
Division of Vascular Surgery and Endovascular Therapy, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX
2 shared publications- Jiawen Li
School of Electrical and Mechanical Engineering, Adelaide University, Adelaide, Australia
2 shared publications Matthew R. Smeds
Department of Surgery, Division of Vascular and Endovascular Surgery, Saint Louis University School of Medicine, Saint Louis, Missouri
2 shared publications
Latest Publications
- 9 October 2025
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 83 (3) , 699-709.e5
Cost-effectiveness analysis of surgical repair versus observation of complex abdominal aortic aneurysms in elderly patients
- 9 October 2025
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 83 (3) , 699-709.e5
Cost-effectiveness analysis of surgical repair versus observation of complex abdominal aortic aneurysms in elderly patients
- Open Access
Estimating the Rupture Risk of Large Abdominal Aortic Aneurysms
Objectives Determining the rupture risk of large abdominal aortic aneurysms (AAA) through clinical studies remains elusive. We sought to employ computational methods on existing literature data and briefly report on stratified rupture risk of large AAAs. Methods We reviewed published English-language literature reporting on rupture risk of large AAAs. Analysis of rupture risk was performed on Microsoft Excel and Visual Basic scripting. Outcome of interest was annual rupture probabilities stratified by aneurysm size (range 5.0/5.5 – 10.0 cm in women/men) and patient sex. Uncertainty in rupture probabilities was considered through probability distributions. Results For aneurysms sized 5.5 – 7.0 cm, estimated annual rupture probabilities in women were much higher than literature-reported estimates in men, ranging from 6.4% (95% confidence interval: 3.5% – 10.1%) to 54.5% (95% confidence interval: 39.3% – 69.3%). For aneurysms sized 7.5 cm, estimated annual rupture probabilities were 32.4% (95% confidence interval: 26.1% – 39.0%) in men and 64.8% (95% confidence interval: 51.3% – 77.1%) in women. For aneurysms sized 10.0 cm, estimated rupture probabilities increased to near-certainty at 96.6% (95% confidence interval: 94.0% – 98.5%) in men and 98.8% (95% confidence interval: 96.8% – 99.9%) in women. Conclusion Computational analysis of existing data is feasible to estimate stratified rupture probabilities of large AAAs, based on aneurysm size and patient sex. Further clinical studies are needed to obtain more precise estimates of rupture probabilities.
Open AccessEstimating the Rupture Risk of Large Abdominal Aortic Aneurysms
Objectives Determining the rupture risk of large abdominal aortic aneurysms (AAA) through clinical studies remains elusive. We sought to employ computational methods on existing literature data and briefly report on stratified rupture risk of large AAAs. Methods We reviewed published English-language literature reporting on rupture risk of large AAAs. Analysis of rupture risk was performed on Microsoft Excel and Visual Basic scripting. Outcome of interest was annual rupture probabilities stratified by aneurysm size (range 5.0/5.5 – 10.0 cm in women/men) and patient sex. Uncertainty in rupture probabilities was considered through probability distributions. Results For aneurysms sized 5.5 – 7.0 cm, estimated annual rupture probabilities in women were much higher than literature-reported estimates in men, ranging from 6.4% (95% confidence interval: 3.5% – 10.1%) to 54.5% (95% confidence interval: 39.3% – 69.3%). For aneurysms sized 7.5 cm, estimated annual rupture probabilities were 32.4% (95% confidence interval: 26.1% – 39.0%) in men and 64.8% (95% confidence interval: 51.3% – 77.1%) in women. For aneurysms sized 10.0 cm, estimated rupture probabilities increased to near-certainty at 96.6% (95% confidence interval: 94.0% – 98.5%) in men and 98.8% (95% confidence interval: 96.8% – 99.9%) in women. Conclusion Computational analysis of existing data is feasible to estimate stratified rupture probabilities of large AAAs, based on aneurysm size and patient sex. Further clinical studies are needed to obtain more precise estimates of rupture probabilities.
- 11 May 2022
- Published by Elsevier in Journal of Surgical Research
- Vol. 277, 342-351
Frequency and Characteristics of Social Media Use among General Surgery Trainees
- 11 May 2022
- Published by Elsevier in Journal of Surgical Research
- Vol. 277, 342-351
Frequency and Characteristics of Social Media Use among General Surgery Trainees
- 1 December 2021
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 74 (6) , 2030-2039.e2
Cost-effectiveness analysis of ankle-brachial index screening in patients with coronary artery disease to optimize medical management
- 1 December 2021
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 74 (6) , 2030-2039.e2
Cost-effectiveness analysis of ankle-brachial index screening in patients with coronary artery disease to optimize medical management
- 15 July 2020
- Published by SAGE Publications in Vascular and Endovascular Surgery
- Vol. 54 (7) , 625-632
Factors Associated With Medication Adherence in Vascular Surgery Patients
Patients with vascular disease have higher mortality rates than age-matched peers and medical management of coexisting diseases may alter these outcomes. We sought to understand factors associated with medication nonadherence in vascular surgery patients at a single University vascular surgery clinic over a 3-month period. Consecutive vascular surgery patients were surveyed from June to August 2019. The survey included demographic questions, the validated Morisky Medication Adherence Scale, the 4-item Patient Health Questionnaire for Anxiety and Depression scales, and other medication-related questions. Medical and surgical histories were retrospectively collected from charts. Univariate and multivariate analyses were used to compare among high, intermediate, and low adherence. A total of 128 (74%) of 174 patients met study inclusion criteria. On univariate analysis, lower medication adherence was associated with younger age (P = .004), anxiety and depression (P = .001), higher daily pain (P < .001), and patients who believed their medications were less important for treating their vascular disease (P < .001). Adherence was not associated with symptomatic vascular disease, gender, education level, marital status, employment, insurance, or the use of medication usage reminders. Multivariate analysis significantly predicted high adherence relative to low adherence with 5-year increase in age (odds ratio [OR] = 1.252, P = .021) and low adherence relative to high adherence with greater perceived pain (OR = 0.839, P = .016). Younger age and high level of pain were associated with lower medication adherence. Informing patients of the importance of prescribed medication and addressing anxiety or depression symptoms may improve adherence.
- 15 July 2020
- Published by SAGE Publications in Vascular and Endovascular Surgery
- Vol. 54 (7) , 625-632
Factors Associated With Medication Adherence in Vascular Surgery Patients
Patients with vascular disease have higher mortality rates than age-matched peers and medical management of coexisting diseases may alter these outcomes. We sought to understand factors associated with medication nonadherence in vascular surgery patients at a single University vascular surgery clinic over a 3-month period. Consecutive vascular surgery patients were surveyed from June to August 2019. The survey included demographic questions, the validated Morisky Medication Adherence Scale, the 4-item Patient Health Questionnaire for Anxiety and Depression scales, and other medication-related questions. Medical and surgical histories were retrospectively collected from charts. Univariate and multivariate analyses were used to compare among high, intermediate, and low adherence. A total of 128 (74%) of 174 patients met study inclusion criteria. On univariate analysis, lower medication adherence was associated with younger age (P = .004), anxiety and depression (P = .001), higher daily pain (P < .001), and patients who believed their medications were less important for treating their vascular disease (P < .001). Adherence was not associated with symptomatic vascular disease, gender, education level, marital status, employment, insurance, or the use of medication usage reminders. Multivariate analysis significantly predicted high adherence relative to low adherence with 5-year increase in age (odds ratio [OR] = 1.252, P = .021) and low adherence relative to high adherence with greater perceived pain (OR = 0.839, P = .016). Younger age and high level of pain were associated with lower medication adherence. Informing patients of the importance of prescribed medication and addressing anxiety or depression symptoms may improve adherence.
- 1 June 2018
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 67 (6) , e218-E218
PC168. Cost-Effectiveness Analysis of Open Surgical Repair versus Fenestrated Endovascular Repair of Pararenal Aneurysms
- 1 June 2018
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 67 (6) , e218-E218
PC168. Cost-Effectiveness Analysis of Open Surgical Repair versus Fenestrated Endovascular Repair of Pararenal Aneurysms
- Open Access
- 18 January 2018
- Published by SAGE Publications in Vascular Medicine
- Vol. 23 (2) , 97-106
Cost-effectiveness analysis of asymptomatic peripheral artery disease screening with the ABI test
Screening for asymptomatic peripheral artery disease (aPAD) with the ankle–brachial index (ABI) test is hypothesized to reduce disease progression and cardiovascular (CV) events by identifying individuals who may benefit from early initiation of medical therapy. Using a Markov model, we evaluated the cost effectiveness of initiating medical therapy (e.g. statin and ACE-inhibitor) after a positive ankle–brachial index (ABI) screen in 65-year-old patients. We modeled progression to symptomatic PAD (sPAD) and CV events with and without ABI screening, evaluating differences in costs and quality-adjusted life years (QALYs). The cost of the ABI test, physician visit, new medication, CV events, and interventions for sPAD were incorporated in the model. We performed sensitivity analysis on model variables with uncertainty. Our model found an incremental cost of US $338 and an incremental QALY of 0.00380 with one-time ABI screening, resulting in an incremental cost-effectiveness ratio (ICER) of $88,758/QALY over a 35-year period. The variables with the largest effects in the ICER were aPAD disease prevalence, cost of monthly medication after a positive screen and 2-year medication adherence rates. Screening high-risk populations, such as tobacco users, where the prevalence of PAD may be 2.5 times higher, decreases the ICER to $24,092/QALY. Our analysis indicates the cost effectiveness of one-time screening for aPAD depends on prevalence, medication costs, and adherence to therapies for CV disease risk reduction. Screening in higher-risk populations under favorable assumptions about medication adherence results in the most favorable cost effectiveness, but limitations in the primary data preclude definitive assessment of cost effectiveness.
- 18 January 2018
- Published by SAGE Publications in Vascular Medicine
- Vol. 23 (2) , 97-106
Open AccessCost-effectiveness analysis of asymptomatic peripheral artery disease screening with the ABI test
Screening for asymptomatic peripheral artery disease (aPAD) with the ankle–brachial index (ABI) test is hypothesized to reduce disease progression and cardiovascular (CV) events by identifying individuals who may benefit from early initiation of medical therapy. Using a Markov model, we evaluated the cost effectiveness of initiating medical therapy (e.g. statin and ACE-inhibitor) after a positive ankle–brachial index (ABI) screen in 65-year-old patients. We modeled progression to symptomatic PAD (sPAD) and CV events with and without ABI screening, evaluating differences in costs and quality-adjusted life years (QALYs). The cost of the ABI test, physician visit, new medication, CV events, and interventions for sPAD were incorporated in the model. We performed sensitivity analysis on model variables with uncertainty. Our model found an incremental cost of US $338 and an incremental QALY of 0.00380 with one-time ABI screening, resulting in an incremental cost-effectiveness ratio (ICER) of $88,758/QALY over a 35-year period. The variables with the largest effects in the ICER were aPAD disease prevalence, cost of monthly medication after a positive screen and 2-year medication adherence rates. Screening high-risk populations, such as tobacco users, where the prevalence of PAD may be 2.5 times higher, decreases the ICER to $24,092/QALY. Our analysis indicates the cost effectiveness of one-time screening for aPAD depends on prevalence, medication costs, and adherence to therapies for CV disease risk reduction. Screening in higher-risk populations under favorable assumptions about medication adherence results in the most favorable cost effectiveness, but limitations in the primary data preclude definitive assessment of cost effectiveness.
- Open Access
- 1 May 2015
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 20 (5) , 056005-8
Optimal flushing agents for integrated optical and acoustic imaging systems
An increasing number of integrated optical and acoustic intravascular imaging systems have been developed and hold great promise for accurately diagnosing vulnerable plaques and guiding atherosclerosis treatment. However, in any intravascular environment, the vascular lumen is filled with blood, a high-scattering source for optical and high-frequency ultrasound signals. Blood must be flushed away to provide clearer images. To our knowledge, no research has been performed to find the ideal flushing agent for combined optical and acoustic imaging techniques. We selected three solutions as potential flushing agents for their image-enhancing effects: mannitol, dextran, and iohexol. Testing of these flushing agents was performed in a closed-loop circulation model and <italic<in vivo</italic< on rabbits. We found that a high concentration of dextran was the most useful for simultaneous intravascular ultrasound and optical coherence tomography imaging.
- 1 May 2015
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 20 (5) , 056005-8
Open AccessOptimal flushing agents for integrated optical and acoustic imaging systems
An increasing number of integrated optical and acoustic intravascular imaging systems have been developed and hold great promise for accurately diagnosing vulnerable plaques and guiding atherosclerosis treatment. However, in any intravascular environment, the vascular lumen is filled with blood, a high-scattering source for optical and high-frequency ultrasound signals. Blood must be flushed away to provide clearer images. To our knowledge, no research has been performed to find the ideal flushing agent for combined optical and acoustic imaging techniques. We selected three solutions as potential flushing agents for their image-enhancing effects: mannitol, dextran, and iohexol. Testing of these flushing agents was performed in a closed-loop circulation model and <italic<in vivo</italic< on rabbits. We found that a high concentration of dextran was the most useful for simultaneous intravascular ultrasound and optical coherence tomography imaging.
- 4 March 2014
- Published by SPIE-Intl Soc Optical Eng
- Vol. 8926, 892635
Diagnostic accuracy of integrated intravascular ultrasound and optical coherence tomography (IVUS-OCT) system for coronary plaque characterization
Intravascular ultrasound (IVUS) imaging and optical coherence tomography (OCT), two commonly used intracoronary imaging modalities, play important roles in plaque evaluation. The combined use of IVUS (to visualize the entire plaque volume) and OCT (to quantify the thickness of the plaque cap, if any) is hypothesized to increase plaque diagnostic accuracy. Our group has developed a fully-integrated dual-modality IVUS-OCT imaging system and 3.6F catheter for simultaneous IVUS-OCT imaging with a high resolution and deep penetration depth. However, the diagnostic accuracy of an integrated IVUS-OCT system has not been investigated. In this study, we imaged 175 coronary artery sites (241 regions of interest) from 20 cadavers using our previous reported integrated IVUS-OCT system. IVUS-OCT images were read by two skilled interventional cardiologists. Each region of interest was classified as either calcification, lipid pool or fibrosis. Comparing the diagnosis by cardiologists using IVUSOCT images with the diagnosis by the pathologist, we calculated the sensitivity and specificity for characterization of calcification, lipid pool or fibrosis with this integrated system. In vitro imaging of cadaver coronary specimens demonstrated the complementary nature of these two modalities for plaques classification. A higher accuracy was shown than using a single modality alone.
- 4 March 2014
- Published by SPIE-Intl Soc Optical Eng
- Vol. 8926, 892635
Diagnostic accuracy of integrated intravascular ultrasound and optical coherence tomography (IVUS-OCT) system for coronary plaque characterization
Intravascular ultrasound (IVUS) imaging and optical coherence tomography (OCT), two commonly used intracoronary imaging modalities, play important roles in plaque evaluation. The combined use of IVUS (to visualize the entire plaque volume) and OCT (to quantify the thickness of the plaque cap, if any) is hypothesized to increase plaque diagnostic accuracy. Our group has developed a fully-integrated dual-modality IVUS-OCT imaging system and 3.6F catheter for simultaneous IVUS-OCT imaging with a high resolution and deep penetration depth. However, the diagnostic accuracy of an integrated IVUS-OCT system has not been investigated. In this study, we imaged 175 coronary artery sites (241 regions of interest) from 20 cadavers using our previous reported integrated IVUS-OCT system. IVUS-OCT images were read by two skilled interventional cardiologists. Each region of interest was classified as either calcification, lipid pool or fibrosis. Comparing the diagnosis by cardiologists using IVUSOCT images with the diagnosis by the pathologist, we calculated the sensitivity and specificity for characterization of calcification, lipid pool or fibrosis with this integrated system. In vitro imaging of cadaver coronary specimens demonstrated the complementary nature of these two modalities for plaques classification. A higher accuracy was shown than using a single modality alone.